by What Is Driving the Growth of the Biotechnology Instruments Market?
The global biotechnology instruments market size was valued at USD 91.11 billion in 2025 and is projected to grow from USD 94.76 billion in 2026 to approximately USD 133.49 billion by 2035, registering a CAGR of 3.89% during the forecast period from 2026 to 2035.
Market Highlights
- North America led the global market with the largest market share of 40% in 2025.
- By product, the life science consumables segment has held the largest revenue share of 55% in 2025.
- By product, the medical laser segment held the largest share in the prepaid card market for 2025.
- By end user, the hospitals & healthcare facilities segment held the largest share in the prepaid card market for 2025.
Biotechnology Instruments Market Overview
The biotechnology instruments market encompasses the development, manufacturing, distribution, and maintenance of advanced tools and equipment used across life sciences, biotechnology, and biomedical research. These instruments, including DNA sequencers, PCR systems, mass spectrometers, chromatography systems, and laboratory incubators, are essential for applications such as genomics, proteomics, drug discovery, clinical diagnostics, and biopharmaceutical research.
Market growth is primarily driven by the rising demand for personalized medicine, precision diagnostics, and advanced genomic research. Increasing investments in biotechnology research, expanding pharmaceutical and biopharmaceutical industries, and continuous technological advancements in laboratory equipment are further accelerating market expansion. Moreover, the growing adoption of laboratory automation technologies, such as robotic liquid handling systems, automated plate readers, and intelligent sample storage solutions, is improving research efficiency, accuracy, and throughput, thereby supporting the continued growth of the biotechnology instruments market.
How is AI contributing to the Biotechnology Instruments Industry?
Artificial intelligence (AI) is playing a transformative role in the biotechnology sector by enhancing research efficiency, accelerating data analysis, and improving decision-making processes. AI-powered technologies enable researchers to process large and complex biological datasets, optimize experimental design, and identify meaningful patterns with greater speed and accuracy. The integration of AI into laboratory workflows has automated repetitive tasks, streamlined data management, and facilitated the interpretation of information from multiple sources. Additionally, AI-driven solutions help reduce human errors, increase research productivity, and support scientific discoveries across areas such as genomics, drug development, and precision medicine, thereby contributing to the growth of the biotechnology instruments market.
Regional Analysis of Biotechnology Instruments Market
U.S. Biotechnology Instruments Market Size and Growth 2026 to 2035
The U.S. biotechnology instruments market size was valued at USD 25.57 billion in 2025 and is projected to grow from USD 26.58 billion in 2026 to approximately USD 37.72 billion by 2035, expanding at a CAGR of 3.96% during the forecast period from 2026 to 2035.
U.S. Biotechnology Instruments Market Trends
The U.S. of America is home to the biggest manufacturers of biotechnology instruments as well as the most influential research activity, which is technologically supported. Automation and artificial intelligence are the main drivers of the operating costs that have been cut in this sector, as well as of the enhanced analyses, and thus, overall, the entire advanced research and laboratory practice.
How is North America leading in the Biotechnology Instruments Market?
North America accounted for more than 40% of the market share in 2025 and dominated the global biotechnology instruments market. The higher adoption rate of the advanced technologies in the biopharmaceutical industries, increased demand for biotechnology instruments, high affordability, and the presence of numerous top market players in US are the prominent factors that drives the growth of the North America biotechnology instruments market. Moreover, the increased demand for the new and innovative drugs, rising investments in the research & development of vaccines, and favorable government support to the pharmaceutical industry has led to the dominance of North America in the global biotechnology instruments market.
How is Asia-Pacific performing in the Biotechnology Instruments Market?
Asia Pacific is estimated to be the most lucrative market during the forecast period. The favorable government investments is attracting FDIs and facilitating the collaborations of the local companies with the foreign companies. This is a major driving force of the biotechnology instruments market. Furthermore, the emerging countries like China, India, Australia, and Japan are inclining towards the utilization of the biotechnology instruments in the agriculture, energy, and environment protection fields, which is fueling the demand for the biotechnology instruments.
Market Segmentation Analysis
Product Insights
How did the Life Science Consumables Segment Dominate the Biotechnology Instruments Market?
The life science consumables segment dominated the biotechnology instruments market in 2025, driven by the consistent demand for reagents, assay kits, cell culture media, and single-use laboratory supplies across research and clinical applications. These consumables are essential for routine operations in biotechnology laboratories, pharmaceutical companies, academic research institutions, and diagnostic centers. The increasing adoption of molecular diagnostics, genomics, and cell-based research, coupled with the expansion of biopharmaceutical R&D and public health initiatives, has significantly increased the need for continuous replenishment of laboratory consumables. Additionally, growing investments in life sciences research and advancements in precision medicine continue to support the segment’s market leadership.
End User Insights
Why did the Hospitals and Healthcare Facilities Segment Dominate the Biotechnology Instruments Market?
The hospitals and healthcare facilities segment dominated the biotechnology instruments market in 2025, owing to the widespread adoption of advanced diagnostic and laboratory instruments for disease detection, clinical testing, and patient care. Hospitals and diagnostic laboratories rely heavily on molecular diagnostic systems, in vitro diagnostic (IVD) instruments, automated nucleic acid extraction systems, and clinical chemistry analyzers to deliver accurate and timely test results. The growing prevalence of chronic and infectious diseases, increasing demand for precision diagnostics, and rising adoption of automated laboratory workflows have further strengthened the segment’s market position. Additionally, continuous investments in healthcare infrastructure and the integration of advanced biotechnology instruments into clinical laboratories continue to drive segment growth.
Top Companies in the Biotechnology Instruments Market & Their Offerings
- AngioDynamics is a medical technology company specializing in minimally invasive devices for vascular access, oncology, and peripheral vascular disease treatment. Its innovative technologies support interventional procedures and improve patient outcomes across healthcare settings.
- Becton, Dickinson, and Company is a global medical technology company that develops diagnostic systems, laboratory instruments, and life science solutions. The company focuses on advancing healthcare through innovations in diagnostics, medication management, and laboratory automation.
- bioMérieux is a leading provider of in vitro diagnostic solutions for detecting infectious diseases and improving patient care. Its portfolio includes microbiology systems, molecular diagnostics, and immunoassay technologies used in clinical laboratories worldwide.
- Bio-Rad Laboratories develops life science research products and clinical diagnostic instruments for academic, pharmaceutical, and healthcare laboratories. Its offerings include PCR systems, chromatography solutions, antibodies, and quality control products.
- BioTek Instruments, Inc. designs and manufactures laboratory instruments for life science research, including microplate readers, washers, and imaging systems. Its products are widely used in drug discovery, cell biology, and biotechnology laboratories.
- Candela Medical develops energy-based medical and aesthetic devices for dermatology, plastic surgery, and cosmetic treatments. The company offers laser and radiofrequency technologies for skin rejuvenation, hair removal, and vascular treatments.
- Cynosure, LLC is a global manufacturer of energy-based aesthetic and medical treatment systems. Its portfolio includes laser, radiofrequency, and body contouring technologies used by dermatologists and aesthetic practitioners worldwide.
Check this report to: ATM Managed Services Market
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview: https://www.precedenceresearch.com/sample/1529
📩You can place an order or ask any questions. Please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344
